Abstract
# {#article-title-2} To the Editor: Drs. French and England1 appropriately point out the importance of comparative effectiveness research. In the accompanying editorial, Drs. Dorsey and Meltzer2 also emphasize that research in this area is important. Comparative medication effectiveness is part of the consideration of medical cost-effectiveness in general, which would also include the value of laboratory studies. For example, what is the value of repeated brain MRI studies in patients with stable multiple sclerosis? Probably minimal. Since comparative medication effectiveness research is important, I thought it was ironic that in the same issue of Neurology ®, Dr. French et al.3 have a research publication where this was not practiced. French et al. investigated brivaracetam (BRV) treatment in seizure patients. Three concentrations of adjunctive BRV …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
